Idylla™ ctBRAF Mutation Assay (RUO)

A revolution in liquid biopsy cancer research

 

The Idylla™ ctBRAF Mutation Assay is the first and only fully automated liquid biopsy assay.

 

Discover the benefits of Idylla™ ctBRAF Assay - the easiest solution to implement liquid biopsy testing in research.

 

  • Directly from 1 ml plasma sample into the cartridge
  • Less than 1 minute hands-on time
  • Total turnaround time of around 100 minutes
  • Detection of all BRAF V600 mutations
  • Highly sensitive & standardized
  • Contamination-controlled design

 

The use of liquid biopsies has the potential to transform cancer diagnostics and extend the
application from disease confirmation to patient monitoring and even early diagnosis.

 

 

Mutation detection

Detection of mutated ctDNA in plasma can complement, or even replace, in certain situations, tissue mutation detection.

 

Monitoring

Monitoring of treatment by means of ctDNA in plasma is a convenient way of regular testing of genetic changes, which is not practically feasible by means of solid biopsies. First, the rate of reduction of targeted mutations can be analysed and patients can be categorized in rapid and slow responders to treatment. Secondly, the emergence of the original targeted mutations and/or new upcoming resistance mutations can be monitored in responding patients. Finally, patients with complete responses can be further monitored for minimal residual disease.

Highly standardized

 

The Idylla™ ctBRAF Mutation Assay, performed on the Biocartis Idylla™ System, is a for “Research Use Only” Assay for the semi-quantitative detection of V600E/E2/D and V600K/R/M mutations in codon 600 of the BRAF gene. The Idylla™ ctBRAF Mutation Assay extracts and amplifies BRAF circulating tumor DNA (ctDNA) from 1 ml of plasma.

 

Prof. B. Neyns, M.D., Ph.D
Medical Oncology, UZ Brussels, Belgium

 

"The Idylla™ System has the potential to allow the start of targeted therapy within a time window of less than 24 hours following the diagnosis of metastasis by analyzing tumor or ctDNA, thereby saving precious time."

 

Not for sale in the USA and Canada. For product availability in your country please contact us via customerservice@biocartis.com.